Deletion of Rv2571c confers resistance to arylamide compounds in <i>Mycobacterium tuberculosis</i>.

Shelton, Catherine D; McNeil, Matthew B; Early, Julie V; Ioerger, Thomas R; Parish, Tanya

Deletion of Rv2571c confers resistance to arylamide compounds in Mycobacterium tuberculosis.

Shelton, Catherine D; McNeil, Matthew B; Early, Julie V; Ioerger, Thomas R; Parish, Tanya.

Afiliación

Shelton CD; Infectious Disease Research Institute, Seattle, WA 98102, USA.
McNeil MB; Infectious Disease Research Institute, Seattle, WA 98102, USA.
Early JV; Infectious Disease Research Institute, Seattle, WA 98102, USA.
Ioerger TR; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA 98109, USA.
Parish T; Department of Computer Science and Engineering, Texas A&M University, College Station, TX 77843, USA.

Antimicrob Agents Chemother ; 65(5)2023 05 01.

Article en En | MEDLINE | ID: mdl-33619059

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Antimicrob Agents Chemother Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos